Greenlight Capital’s Carter's CRI Stock Holding History

Greenlight Capital’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-58,000	Closed	-$6.82M	–	39
2017 Q4	$6.82M	Buy	+58,000	New	+$6.01M	0.12%	33

Other funds holding CRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Greenlight Capital's CRI Position: Q1 2018 in Review

Greenlight Capital sold out of Carter's (CRI) in Q1 2018, closing a stake of 58,000 shares — an estimated $6.82M sold.

Greenlight Capital first reported a position in CRI in Q4 2017 and held it in 1 quarter. The position peaked at $6.82M in Q4 2017. 384 funds tracked by Wall St. Rank hold CRI as of Q1 2018.

Greenlight Capital reported no remaining Carter's position as of Q1 2018 after selling out during the quarter.
Greenlight Capital sold 58,000 Carter's shares in Q1 2018, an estimated $6.82M.
Greenlight Capital first reported a position in Carter's in Q4 2017 and held it in 1 quarter.
Greenlight Capital's Carter's position peaked at $6.82M in Q4 2017.
384 funds tracked by Wall St. Rank held Carter's as of Q1 2018.

Based on Greenlight Capital's 13F filing for Q1 2018, filed 15 May 2018.